ARCHIVES

Potti Claimed Rhodes Credential in Bio Submitted for DOD Funding

This article is from The Cancer Letter archive.

Vol. 36 No. 29 | July 30, 2010

Download PDF Visit The Full Archive

Related Articles

FDA Proposes New User Fees for Generics and Biosimilar Products

January 20, 2012

Assurances On Methods For Misconduct Reporting Required

December 1, 1989

FDA Approves Lilly’s Alimta For Metastatic NSCLC

August 27, 2004

Drug Discovery Group Announcement Issued

January 7, 1983

Wanted: Methods To Measure Or Estimate Renal Function For Dosing Cancer Drugs

October 15, 2010

Clinical Education Grants Held To 170 Payline, No New Awards; Organ Site Renewals Limited To 180

March 26, 1982